Red blood cell damage defines the etiology of hepatic sinusoidal obstruction syndrome induced by pyrrolizidine alkaloids
Acta Pharmaceutica Sinica B · 2026-05 · 16 (5) · 3059-3073
DOI: 10.1016/j.apsb.2026.03.023 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Pharmaceutica Sinica B, 2026-05. Verfasst von Zijing Song und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Guangdong Provincial Natural Science Foundation, Basic and Applied Basic Research Foundation of Guangdong Province, University Grants Committee Research Grants Council.
Abstract (Originalsprache)
Hepatic sinusoidal obstruction syndrome (HSOS), a life-threatening liver disease characterized by sinusoidal endothelial cell (LSEC) damage, is frequently caused by pyrrolizidine alkaloid (PA) exposure present in numerous herb or food products. Unlike other hepatotoxins, the precise mechanism by which PAs selectively target LSECs remains poorly understood, posing significant challenges to the development of effective treatments. This study identified hemolysis as the initiating event in PA-HSOS pathogenesis through clinical and animal model analyses. PA exposure induced red blood cell (RBC) rupture, releasing free hemoglobin (Hb) that directly damaged LSECs. Mechanistic investigations revealed that PA-formed protein adducts with haptoglobin (Hp), impairing its protective effect against toxic Hb and triggering a cascade of LSEC activation, ferroptosis, and hemorrhagic liver necrosis. Rescue study revealed that Hp supplementation effectively mitigated PA-induced liver injury by scavenging free Hb. Clinical validation demonstrated elevated Hb-Hp adducts and cell-free Hb in PA-HSOS patients, confirming concordant intoxication mechanisms across species. The findings redefine PA-HSOS as a hematogenous liver disorder originating from RBC destabilization, rather than direct hepatocyte toxicity. This hematopathological perspective reveals Hp replacement therapy as a promising etiological treatment strategy, addressing the root cause rather than secondary liver damage.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China.
- School of Medicine, The Chinese University of Hong Kong, Shenzhen 518172, China.
- Department of Gastroenterology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University School of Medicine, Nanjing 210008, China.
Förderung
- Guangdong Provincial Natural Science Foundation
- Basic and Applied Basic Research Foundation of Guangdong Province
- University Grants Committee Research Grants Council
Zitieren
APA
Song, Z., He, Y., Zhang, W., Lian, W., Pan, Y., Ma, J., Zhao, Y., Huang, T., Zhuge, Y., & Lin, G. (2026). Red blood cell damage defines the etiology of hepatic sinusoidal obstruction syndrome induced by pyrrolizidine alkaloids. Acta Pharmaceutica Sinica B, 16(5), 3059-3073. https://doi.org/10.1016/j.apsb.2026.03.023
Vancouver
Song Z, He Y, Zhang W, Lian W, Pan Y, Ma J, et al. Red blood cell damage defines the etiology of hepatic sinusoidal obstruction syndrome induced by pyrrolizidine alkaloids. Acta Pharmaceutica Sinica B. 2026;16(5):3059-3073. doi:10.1016/j.apsb.2026.03.023
BibTeX
@article{Song2026,
author = {Song, Zijing and He, Yisheng and Zhang, Wei and Lian, Wei and Pan, Yueyang and Ma, Jiang and Zhao, Yuxuan and Huang, Tianyang and Zhuge, Yuzheng and Lin, Ge},
title = {Red blood cell damage defines the etiology of hepatic sinusoidal obstruction syndrome induced by pyrrolizidine alkaloids},
journal = {Acta Pharmaceutica Sinica B},
year = {2026},
volume = {16},
number = {5},
pages = {3059--3073},
doi = {10.1016/j.apsb.2026.03.023}
}
EUVIMED